世界の神経因性疼痛治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV03956)
◆英語タイトル:Global Neuropathic Pain Drugs Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV03956
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは神経因性疼痛治療薬の世界市場について調査・分析した資料です。種類別(三環系抗うつ薬抗けいれん薬、セロトニン・ノルエピネフリン再取り込み阻害薬、カプサイシンクリーム、局所麻酔薬、オピオイド、ステロイド、その他)の市場規模、用途別(病院薬局、小売薬局、オンライン薬局)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別神経因性疼痛治療薬の競争状況、市場シェア
・世界の神経因性疼痛治療薬市場:種類別市場規模 2015年-2020年(三環系抗うつ薬抗けいれん薬、セロトニン・ノルエピネフリン再取り込み阻害薬、カプサイシンクリーム、局所麻酔薬、オピオイド、ステロイド、その他)
・世界の神経因性疼痛治療薬市場:種類別市場規模予測 2021年-2026年(三環系抗うつ薬抗けいれん薬、セロトニン・ノルエピネフリン再取り込み阻害薬、カプサイシンクリーム、局所麻酔薬、オピオイド、ステロイド、その他)
・世界の神経因性疼痛治療薬市場:用途別市場規模 2015年-2020年(病院薬局、小売薬局、オンライン薬局)
・世界の神経因性疼痛治療薬市場:用途別市場規模予測 2021年-2026年(病院薬局、小売薬局、オンライン薬局)
・北米の神経因性疼痛治療薬市場分析:米国、カナダ
・ヨーロッパの神経因性疼痛治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの神経因性疼痛治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の神経因性疼痛治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの神経因性疼痛治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Johnson & Johnson、Sanofi、GlaxoSmithKline、Eli Lilly、Bristol-Myers Squibb、Biogen、Baxter Healthcare、Depomed
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.

Market Analysis and Insights: Global Neuropathic Pain Drugs Market
The global Neuropathic Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Neuropathic Pain Drugs Scope and Market Size
Neuropathic Pain Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuropathic Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed

Market segment by Type, the product can be split into
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuropathic Pain Drugs Revenue
1.4 Market by Type
1.4.1 Global Neuropathic Pain Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tricyclic Anti-Depressants Anticonvulsants
1.4.3 Serotonin-Norepinephrine Reuptake Inhibitor
1.4.4 Capsaicin Cream
1.4.5 Local Anaesthesia
1.4.6 Opioids
1.4.7 Steroids
1.4.8 Others
1.5 Market by Application
1.5.1 Global Neuropathic Pain Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Neuropathic Pain Drugs Market Perspective (2015-2026)
2.2 Global Neuropathic Pain Drugs Growth Trends by Regions
2.2.1 Neuropathic Pain Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuropathic Pain Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Neuropathic Pain Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Neuropathic Pain Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Neuropathic Pain Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Pain Drugs Players by Market Size
3.1.1 Global Top Neuropathic Pain Drugs Players by Revenue (2015-2020)
3.1.2 Global Neuropathic Pain Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Neuropathic Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuropathic Pain Drugs Market Concentration Ratio
3.2.1 Global Neuropathic Pain Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Drugs Revenue in 2019
3.3 Neuropathic Pain Drugs Key Players Head office and Area Served
3.4 Key Players Neuropathic Pain Drugs Product Solution and Service
3.5 Date of Enter into Neuropathic Pain Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Neuropathic Pain Drugs Historic Market Size by Type (2015-2020)
4.2 Global Neuropathic Pain Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Neuropathic Pain Drugs Market Size by Application (2015-2020)
5.2 Global Neuropathic Pain Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Neuropathic Pain Drugs Market Size (2015-2020)
6.2 Neuropathic Pain Drugs Key Players in North America (2019-2020)
6.3 North America Neuropathic Pain Drugs Market Size by Type (2015-2020)
6.4 North America Neuropathic Pain Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Neuropathic Pain Drugs Market Size (2015-2020)
7.2 Neuropathic Pain Drugs Key Players in Europe (2019-2020)
7.3 Europe Neuropathic Pain Drugs Market Size by Type (2015-2020)
7.4 Europe Neuropathic Pain Drugs Market Size by Application (2015-2020)

8 China
8.1 China Neuropathic Pain Drugs Market Size (2015-2020)
8.2 Neuropathic Pain Drugs Key Players in China (2019-2020)
8.3 China Neuropathic Pain Drugs Market Size by Type (2015-2020)
8.4 China Neuropathic Pain Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Neuropathic Pain Drugs Market Size (2015-2020)
9.2 Neuropathic Pain Drugs Key Players in Japan (2019-2020)
9.3 Japan Neuropathic Pain Drugs Market Size by Type (2015-2020)
9.4 Japan Neuropathic Pain Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Neuropathic Pain Drugs Market Size (2015-2020)
10.2 Neuropathic Pain Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuropathic Pain Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Neuropathic Pain Drugs Market Size by Application (2015-2020)

11 India
11.1 India Neuropathic Pain Drugs Market Size (2015-2020)
11.2 Neuropathic Pain Drugs Key Players in India (2019-2020)
11.3 India Neuropathic Pain Drugs Market Size by Type (2015-2020)
11.4 India Neuropathic Pain Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Neuropathic Pain Drugs Market Size (2015-2020)
12.2 Neuropathic Pain Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuropathic Pain Drugs Market Size by Type (2015-2020)
12.4 Central & South America Neuropathic Pain Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Neuropathic Pain Drugs Introduction
13.1.4 Pfizer Revenue in Neuropathic Pain Drugs Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Neuropathic Pain Drugs Introduction
13.2.4 Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview
13.3.3 Sanofi Neuropathic Pain Drugs Introduction
13.3.4 Sanofi Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Neuropathic Pain Drugs Introduction
13.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Eli Lilly
13.5.1 Eli Lilly Company Details
13.5.2 Eli Lilly Business Overview
13.5.3 Eli Lilly Neuropathic Pain Drugs Introduction
13.5.4 Eli Lilly Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.5.5 Eli Lilly Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Introduction
13.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Biogen
13.7.1 Biogen Company Details
13.7.2 Biogen Business Overview
13.7.3 Biogen Neuropathic Pain Drugs Introduction
13.7.4 Biogen Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.7.5 Biogen Recent Development
13.8 Baxter Healthcare
13.8.1 Baxter Healthcare Company Details
13.8.2 Baxter Healthcare Business Overview
13.8.3 Baxter Healthcare Neuropathic Pain Drugs Introduction
13.8.4 Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.8.5 Baxter Healthcare Recent Development
13.9 Depomed
13.9.1 Depomed Company Details
13.9.2 Depomed Business Overview
13.9.3 Depomed Neuropathic Pain Drugs Introduction
13.9.4 Depomed Revenue in Neuropathic Pain Drugs Business (2015-2020)
13.9.5 Depomed Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Pfizer、Johnson & Johnson、Sanofi、GlaxoSmithKline、Eli Lilly、Bristol-Myers Squibb、Biogen、Baxter Healthcare、Depomed

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の神経因性疼痛治療薬市場2026:インサイト・予測(Global Neuropathic Pain Drugs Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。